Vactosertib, TGF-β receptor I inhibitor, augments the sensitization of the anti-cancer activity of gemcitabine in pancreatic cancer.
Lee JE, Lee P, Yoon YC, Han BS, Ko S, Park MS, Lee YJ, Kim SE, Cho YJ, Lim JH, Ryu JK, Shim S, Kim DK, Jung KH, Hong SS.
Lee JE, et al. Among authors: shim s.
Biomed Pharmacother. 2023 Jun;162:114716. doi: 10.1016/j.biopha.2023.114716. Epub 2023 Apr 20.
Biomed Pharmacother. 2023.
PMID: 37086509
Free article.